Intellia (NTLA) - Kapitalisasi marang bathi

Lambang korporat lan logo Intellia Therapeutics Inc (NTLA)

Intellia Therapeutics (NTLA) is developing CRISPR therapies to combat rare genetic pathologies. Business growth is independent of economic cycles, relying instead on the success of clinical trials and venture capital. Automated laboratories are accelerating drug development, as reflected in the price-to-earnings dynamics. The value of -3.20 determines this parameter level on this chart.

NTLA - Rasio rega marang bathi intelliatx.com ing rentang 04.07.2022 - 15.11.2026

Rincian metrik komprehensif lan analitis Intellia Corp (NTLA)

- rega saham lan konsensus proyeksi valuasi:
Analisis umum perusahaan:Intellia - NTLA
Produk asil prodhuksi Intellia

Intellia Therapeutics (NTLA), which develops CRISPR technologies through global alliances, demonstrates specific valuation characteristics via the P/E ratio, which correlates market capitalization with net income to determine the payback period of assets. The current value of -3.20 reflects market expectations for future breakthroughs in genome editing; therefore, the issuer's P/E history allows investors to distinguish fundamental growth from speculative overheating of the business value.

Perusahaan pesaing

tempus.com - Kapitalisasi marang bathi resik|Pangali P/E QGEN|Periode bali modal bisnis Isis Pharmaceuticals|Pangali P/E RGEN (repligen.com)|Rasio rega pasar marang bathi resik RNA (Avidity Biosciences, Inc.)|CRSP - Rasio rega marang bathi|Nilai perusahaan marang bathi resik WGS (GeneDx)|RARE: Pangali P/E|Beam Therapeutics Corp - Nilai perusahaan marang bathi resik|Koefisien rega marang bathi SRPT|twistbioscience.com (TWST) - Periode bali modal bisnis|Pangali P/E TXG|STOK - Kapitalisasi marang bathi|Rasio rega marang bathi biolifesolutions.com BLFS|Periode bali modal bisnis Wave Life Sciences Corp (WVE)|MAZE - Rasio rega marang bathi|Nilai perusahaan marang bathi resik SION (Sionna Therapeutics Inc)|PRME: Pangali P/E|Taysha - Nilai perusahaan marang bathi resik|Rasio rega marang bathi uniQure NV|Pangali rega marang bathi MGTX (MeiraGTx PLC)|Koefisien rega marang bathi RGNX (regenxbio.com)|Solid Biosciences Inc. - Pangali rega marang bathi|Rasio rega marang bathi Ocugen Corp OCGN|Pacific Biosciences of California, Inc. (PACB) - Kapitalisasi marang bathi|BNTC - Rasio rega marang bathi|Design Pharma - Rasio rega pasar marang bathi resik|RCKT (Rocket Pharmaceuticals Inc) - Koefisien rega marang bathi|4D Molecular Therapeutics (FDMT) - Pangali P/E|Rasio rega marang bathi Lexeo Therapeutics, Inc.|Kapitalisasi marang bathi Korro Bio, Inc. KRRO|Pangali P/E EDIT|Periode bali modal bisnis Silence Therapeutics Corp|Rasio rega marang bathi proqr.com PRQR|CDXS - Koefisien rega marang bathi|SGMO - Rasio rega marang bathi|Rasio kapitalisasi marang bathi resik Nautilus Biotechnology, Inc. (NAUT)|MGX: Pangali P/E|Pangali rega marang bathi DTIL|GBIO (Generation Bio) - Pangali P/E|Pangali rega marang bathi BOLD (boundlessbio.com)|Koefisien rega marang bathi XCUR (exicuretx.com)|Celsion Corporation - Pangali rega marang bathi|Pangali P/E PHIO (phiopharma.com)|Pangali P/E Mustang Bio, Inc. MBIO|RNAZ: Koefisien rega marang bathi|BNGO (Bionano Genomics) - Pangali rega marang bathi|APDN: Pangali P/E|bluebird bio (BLUE) - Pangali P/E|Rasio rega marang bathi ImmunoPrecise Antibodies Ltd.|Kapitalisasi marang bathi Omega OMGA|Pangali P/E OMIC|RGLS - Kapitalisasi marang bathi|Syros Pharmaceuticals, Inc - Koefisien rega marang bathi|Periode bali modal bisnis Codex DNA (TBIO)|TCON - Rasio rega marang bathi|UBX: Rasio rega marang bathi